Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242426 | SCV000315004 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000242426 | SCV000518086 | benign | not specified | 2016-01-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001510405 | SCV001717428 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001510405 | SCV002031729 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001789313 | SCV002031731 | benign | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004708164 | SCV005241085 | benign | not provided | criteria provided, single submitter | not provided |